CD19 and non-Hodgkin lymphoma: A recent high-profile study by Liu et al. investigated HLA-mismatched, cord blood-derived CD19 CAR-NK cells expressing IL-15 and an inducible cas-9 safety switch in patients with relapsed or refractory CD19+ NHL [6].